BioMAdvanced Diagnostics aims to become a key player in biomarker diagnostics, both in France and internationally, starting with tests for immune responses that allow for the adjustment of treatments for patients who have either undergone an organ transplant (kidney or lung) or are suffering from Ulcerative Colitis (UC). The use of diagnostic tests will lead to a significant improvement in patients’ quality of life, and potentially an extension of their life expectancy